Mount Sinai Obstetricians First in New York City to Use FDA-Cleared AI Tool That Enhances Fetal Screenings for Congenital Heart Defects

New York, NY - (December 02, 2025)

Doctors in the Raquel and Jaime Gilinski Department of Obstetrics, Gynecology and Reproductive Science at Mount Sinai have become the first in New York City to implement an artificial intelligence (AI) tool that enhances ultrasounds on a large scale—resulting in earlier detection and better care for babies and families. 

Congenital heart defects, or conditions present at birth that affect the heart structure, are one of the most common birth abnormalities. About 1 in 500 newborns is classified as having a severe congenital heart defect that requires urgent medical or surgical intervention for survival, according to the National Institutes of Health.  

Carnegie Imaging for Women, a modern OB/GYN imaging facility, is the first center in New York City to use a Food and Drug Administration-cleared AI software tool from medical company BrightHeart to make ultrasounds more accurate and efficient. The Mount Sinai-affiliated center has three locations in Manhattan.  

Continue reading the full press release here.